The National Institute for Health and Care Excellence, NICE, decides whether the health service in England should pay for a treatment. For years it used a cost-effectiveness range of £20,000 to £30,000 per quality-adjusted life year, or QALY, gained. A treatment had to show how much health it bought for its price.
NICE has since confirmed a new range of £25,000 to £35,000 per QALY gained, from April 2026.